Type I interferon underlies severe disease associated with Junín virus infection in mice

  1. Brady T Hickerson
  2. Eric J Sefing
  3. Kevin W Bailey
  4. Arnaud J Van Wettere
  5. Manuel L Penichet
  6. Brian B Gowen  Is a corresponding author
  1. Utah State University, United States
  2. University of California, Los Angeles, United States

Abstract

Junín virus (JUNV) is one of five New World mammarenaviruses (NWMs) that cause fatal hemorrhagic disease in humans and is the etiological agent of Argentine hemorrhagic fever (AHF). The pathogenesis underlying AHF is poorly understood; however, a prolonged, elevated interferon-a (IFN-a) response is associated with a negative disease outcome. A feature of all NWMs that cause viral hemorrhagic fever is the use of human transferrin receptor 1 (hTfR1) for cellular entry. Here, we show that mice expressing hTfR1 develop a lethal disease course marked by an increase in serum IFN-a concentration when challenged with JUNV. Further, we provide evidence that the type I IFN response is central to the development of severe JUNV disease in hTfR1 mice. Our findings identify TfR1-mediated entry and the type I IFN response as key factors in the pathogenesis of JUNV infection in mice.

Data availability

All data generated or analyzed during this study are included in the manuscript.

Article and author information

Author details

  1. Brady T Hickerson

    Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, United States
    Competing interests
    No competing interests declared.
  2. Eric J Sefing

    Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, United States
    Competing interests
    No competing interests declared.
  3. Kevin W Bailey

    Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, United States
    Competing interests
    No competing interests declared.
  4. Arnaud J Van Wettere

    Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, United States
    Competing interests
    No competing interests declared.
  5. Manuel L Penichet

    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States
    Competing interests
    Manuel L Penichet, is a shareholder of Klyss Biotech, Inc. The Regents of the University of California licensed Dr. Penichet's technology to this firm. The author has no other competing interests to declare..
  6. Brian B Gowen

    Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, United States
    For correspondence
    brian.gowen@usu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9113-2575

Funding

National Institutes of Health (R56 AI13646)

  • Brian B Gowen

National Institutes of Health (R01 AI14110)

  • Brian B Gowen

National Institutes of Health (R01 CA196266)

  • Manuel L Penichet

Utah State University (Graduate Research and Creative Opportunities grant)

  • Brady T Hickerson

The funders had no role in study design, data collection and interpretation or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures complied with USDA guidelines and were conducted at the AAALAC-accredited laboratory animal research facilities at Utah State University under protocol #10034, approved by the Utah State University Institutional Animal Care and Use Committee.

Copyright

© 2020, Hickerson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,327
    views
  • 148
    downloads
  • 11
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Brady T Hickerson
  2. Eric J Sefing
  3. Kevin W Bailey
  4. Arnaud J Van Wettere
  5. Manuel L Penichet
  6. Brian B Gowen
(2020)
Type I interferon underlies severe disease associated with Junín virus infection in mice
eLife 9:e55352.
https://doi.org/10.7554/eLife.55352

Share this article

https://doi.org/10.7554/eLife.55352

Further reading

    1. Microbiology and Infectious Disease
    Maneesh Kumar Singh, Victoria Ann Bonnell ... Celia RS Garcia
    Research Article

    Dynamic control of gene expression is critical for blood stage development of malaria parasites. Here, we used multi-omic analyses to investigate transcriptional regulation by the chromatin-associated microrchidia protein, MORC, during asexual blood stage development of the human malaria parasite Plasmodium falciparum. We show that PfMORC (PF3D7_1468100) interacts with a suite of nuclear proteins, including APETALA2 (ApiAP2) transcription factors (PfAP2-G5, PfAP2-O5, PfAP2-I, PF3D7_0420300, PF3D7_0613800, PF3D7_1107800, and PF3D7_1239200), a DNA helicase DS60 (PF3D7_1227100), and other chromatin remodelers (PfCHD1 and PfEELM2). Transcriptomic analysis of PfMORCHA-glmS knockdown parasites revealed 163 differentially expressed genes belonging to hypervariable multigene families, along with upregulation of genes mostly involved in host cell invasion. In vivo genome-wide chromatin occupancy analysis during both trophozoite and schizont stages of development demonstrates that PfMORC is recruited to repressed, multigene families, including the var genes in subtelomeric chromosomal regions. Collectively, we find that PfMORC is found in chromatin complexes that play a role in the epigenetic control of asexual blood stage transcriptional regulation and chromatin organization.

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Michael B Hall, Ryan R Wick ... Lachlan Coin
    Research Article

    Variant calling is fundamental in bacterial genomics, underpinning the identification of disease transmission clusters, the construction of phylogenetic trees, and antimicrobial resistance detection. This study presents a comprehensive benchmarking of variant calling accuracy in bacterial genomes using Oxford Nanopore Technologies (ONT) sequencing data. We evaluated three ONT basecalling models and both simplex (single-strand) and duplex (dual-strand) read types across 14 diverse bacterial species. Our findings reveal that deep learning-based variant callers, particularly Clair3 and DeepVariant, significantly outperform traditional methods and even exceed the accuracy of Illumina sequencing, especially when applied to ONT’s super-high accuracy model. ONT’s superior performance is attributed to its ability to overcome Illumina’s errors, which often arise from difficulties in aligning reads in repetitive and variant-dense genomic regions. Moreover, the use of high-performing variant callers with ONT’s super-high accuracy data mitigates ONT’s traditional errors in homopolymers. We also investigated the impact of read depth on variant calling, demonstrating that 10× depth of ONT super-accuracy data can achieve precision and recall comparable to, or better than, full-depth Illumina sequencing. These results underscore the potential of ONT sequencing, combined with advanced variant calling algorithms, to replace traditional short-read sequencing methods in bacterial genomics, particularly in resource-limited settings.